A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Due to high demand of Triaz, Ziana, and Solodyn sales have been up and should continue to keep going up. They also have a strong group of products to help reduce acne. Medics continue to spend a lot of time and money to develop new products and improve their already strong list of products, this should help them keep increasing their earnings in the future. They currently have a great balance sheet, with a lot of cash and not much debt, this could be used for a number of different things but most likely will be used to increase their R&D.